Literature DB >> 1903775

Shift of excretory-secretory immunogens of Trypanosoma cruzi during human Chagas' disease.

E E Jazín1, A O Luquetti, A Rassi, A C Frasch.   

Abstract

We studied secreted-excreted immunogens in human patients infected with Trypanosoma cruzi. A pair of 45- to 55-kDa antigens and a family of shed acute-phase antigens characterized the acute phase, while antibodies against a 160- to 170-kDa immunogen appeared at the chronic phase of the disease.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1903775      PMCID： PMC257986          DOI： 10.1128/iai.59.6.2189-2191.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  14 in total

1.  Protective immunisation of mice using cell surface glycoprotein from Trypanosoma cruzi.

Authors:  M T Scott; D Snary
Journal:  Nature       Date:  1979-11-01       Impact factor: 49.962

2.  Characterization of major surface and excretory-secretory immunogens of Trypanosoma cruzi trypomastigotes and identification of potential protective antigen.

Authors:  M A Ouaissi; A Taibi; J Cornette; P Velge; B Marty; M Loyens; M Esteva; F S Rizvi; A Capron
Journal:  Parasitology       Date:  1990-02       Impact factor: 3.234

3.  Fetal IgG specificities against Trypanosoma cruzi antigens in infected newborns.

Authors:  M B Reyes; M Lorca; P Muñoz; A C Frasch
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

4.  Proteases secreted by transforming schistosomula of Schistosoma mansoni promote resistance to killing by complement.

Authors:  M Marikovsky; R Arnon; Z Fishelson
Journal:  J Immunol       Date:  1988-07-01       Impact factor: 5.422

5.  Immunity against infection with Trypanosoma cruzi in mice correlates with presence of antibodies against three trypomastigote polypeptides.

Authors:  H J Zweerink; H D Weston; O F Andersen; S S Garber; E C Hayes
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

6.  Comparative studies on infectivity and surface carbohydrates of several strains of Trypanosoma cruzi.

Authors:  S M González Cappa; A M Katzin; N Añasco; S Lajmanovich
Journal:  Medicina (B Aires)       Date:  1981       Impact factor: 0.653

7.  Purification of a Trypanosoma cruzi membrane glycoprotein which elicits lytic antibodies.

Authors:  K A Norris; G Harth; M So
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

8.  Developmentally regulated expression by Trypanosoma cruzi of molecules that accelerate the decay of complement C3 convertases.

Authors:  M T Rimoldi; A Sher; S Heiny; A Lituchy; C H Hammer; K Joiner
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

9.  Identification of a Trypanosoma cruzi antigen that is shed during the acute phase of Chagas' disease.

Authors:  J L Affranchino; C F Ibañez; A O Luquetti; A Rassi; M B Reyes; R A Macina; L Aslund; U Pettersson; A C Frasch
Journal:  Mol Biochem Parasitol       Date:  1989-05-15       Impact factor: 1.759

10.  Attachment of Trypanosoma cruzi trypomastigotes to receptors at restricted cell surface domains.

Authors:  S Schenkman; C Diaz; V Nussenzweig
Journal:  Exp Parasitol       Date:  1991-01       Impact factor: 2.011
View more
  8 in total

1.  Excretory-secretory antigens of Trypanosoma cruzi are potentially useful for serodiagnosis of chronic Chagas' disease.

Authors:  M Nakazawa; D S Rosa; V R Pereira; M O Moura; V C Furtado; W V Souza; M N Barros; F G Abath; Y M Gomes
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

2.  Cavia porcellus as a model for experimental infection by Trypanosoma cruzi.

Authors:  Yagahira E Castro-Sesquen; Robert H Gilman; Verónica Yauri; Noelia Angulo; Manuela Verastegui; Daniel E Velásquez; Charles R Sterling; Diana Martin; Caryn Bern
Journal:  Am J Pathol       Date:  2011-05-14       Impact factor: 4.307

3.  Immunoblot assay using excreted-secreted antigens of Trypanosoma cruzi in serodiagnosis of congenital, acute, and chronic Chagas' disease.

Authors:  E S Umezawa; M S Nascimento; N Kesper; J R Coura; J Borges-Pereira; A C Junqueira; M E Camargo
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

4.  Reactivity of chagasic antigal antibodies with noninfected cells treated with Trypanosoma cruzi secreted/excreted antigens.

Authors:  J K Yokoyama-Yasunaka; R M Piazza; E S Umezawa; A M Stolf
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

5.  Domestic Pig (Sus scrofa) as an Animal Model for Experimental Trypanosoma cruzi Infection.

Authors:  Verónica Yauri; Yagahira E Castro-Sesquen; Manuela Verastegui; Noelia Angulo; Fernando Recuenco; Ines Cabello; Edith Malaga; Caryn Bern; Cesar M Gavidia; Robert H Gilman
Journal:  Am J Trop Med Hyg       Date:  2016-02-29       Impact factor: 2.345

6.  Identification of the gene(s) coding for the trans-sialidase of Trypanosoma cruzi.

Authors:  A J Parodi; G D Pollevick; M Mautner; A Buschiazzo; D O Sanchez; A C Frasch
Journal:  EMBO J       Date:  1992-05       Impact factor: 11.598

7.  Cell death and serum markers of collagen metabolism during cardiac remodeling in Cavia porcellus experimentally infected with Trypanosoma cruzi.

Authors:  Yagahira E Castro-Sesquen; Robert H Gilman; Henry Paico; Verónica Yauri; Noelia Angulo; Fredy Ccopa; Caryn Bern
Journal:  PLoS Negl Trop Dis       Date:  2013-02-07

8.  Detection of soluble antigen and DNA of Trypanosoma cruzi in urine is independent of renal injury in the guinea pig model.

Authors:  Yagahira E Castro-Sesquen; Robert H Gilman; Verónica Yauri; Jaime Cok; Noelia Angulo; Hermes Escalante; Caryn Bern
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.